Patents by Inventor Arik Dahan

Arik Dahan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Conjugates of a phospholipid and a drug for the treatment of inflammatory bowel disease
    Patent number: 10716800
    Abstract: Conjugates of drugs suitable for use in the treatment of inflammatory bowel disease and phospholipids, and their use in the treatment of inflammatory bowel disease, are disclosed. The disclosed conjugates serve as targeted prodrugs which are suitable for oral administration, and which are capable of releasing the drug selectively at the diseased tissue upon activation by PLA2.
    Type: Grant
    Filed: July 11, 2016
    Date of Patent: July 21, 2020
    Assignee: Ben-Gurion University of the Negev Research and Development Authority
    Inventor: Arik Dahan
  • CONJUGATES OF A PHOSPHOLIPID AND A DRUG FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Publication number: 20160317558
    Abstract: Conjugates of drugs suitable for use in the treatment of inflammatory bowel disease and phospholipids, and their use in the treatment of inflammatory bowel disease, are disclosed. The disclosed conjugates serve as targeted prodrugs which are suitable for oral administration, and which are capable of releasing the drug selectively at the diseased tissue upon activation by PLA2.
    Type: Application
    Filed: July 11, 2016
    Publication date: November 3, 2016
    Applicant: Ben-Gurion University of the Negev Research and Development Authority
    Inventor: Arik DAHAN
  • CONJUGATES OF A PHOSPHOLIPID AND A DRUG FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Publication number: 20150065462
    Abstract: Conjugates of drugs suitable for use in the treatment of inflammatory bowel disease and phospholipids, and their use in the treatment of inflammatory bowel disease, are disclosed. The disclosed conjugates serve as targeted prodrugs which are suitable for oral administration, and which are capable of releasing the drug selectively at the diseased tissue upon activation by PLA2.
    Type: Application
    Filed: November 10, 2014
    Publication date: March 5, 2015
    Inventor: Arik DAHAN
  • CONJUGATES OF A PHOSPHOLIPID AND A DRUG FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Publication number: 20130244982
    Abstract: Conjugates of drugs suitable for use in the treatment of inflammatory bowel disease and phospholipids, and their use in the treatment of inflammatory bowel disease, are disclosed. The disclosed conjugates serve as targeted prodrugs which are suitable for oral administration, and which are capable of releasing the drug selectively at the diseased tissue upon activation by PLA2.
    Type: Application
    Filed: December 1, 2011
    Publication date: September 19, 2013
    Applicant: Bengurion University of the Negev Research and Development Authority
    Inventor: Arik Dahan